Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Edson

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
ACS Nano|August 22, 2018
Cancer Cell-Derived, Drug-Loaded Nanovesicles Induced by Sulfhydryl-Blocking for Effective and Safe Cancer TherapyDominique Ingato, Julius A Edson, Michael Zakharian, et al.
Biomacromolecules|March 22, 2018
Aqueous-Soluble, Acid-Transforming Chitosan for Efficient and Stimuli-Responsive Gene SilencingJulius A Edson, Dominique Ingato, Shirley Wu, et al.
Molecular & General Genetics : MGG|May 1, 1988
Early-blocked sporulation mutations alter expression of enzymes under carbon control in Bacillus subtilisS A Boylan, K T Chun, B A Edson, et al.
Cancer Research|October 15, 1990
Antitumor activity of adriamycin (hydrazone-linked) immunoconjugates compared with free adriamycin and specificity of tumor cell killingG R Braslawsky, M A Edson, W Pearce, et al.
Molecular and Cellular Biology|February 24, 2010
TEX14 interacts with CEP55 to block cell abscissionTokuko Iwamori, Naoki Iwamori, Lang Ma, et al.
Plos Genetics|October 27, 2011
Transforming growth factor β receptor type 1 is essential for female reproductive tract integrity and functionQinglei Li, Julio E Agno, Mark A Edson, et al.
Macromolecular Bioscience|April 19, 2021
Eradication of Intracellular Salmonella Typhimurium by Polyplexes of Acid-Transforming Chitosan and Fragment DNAJulius A Edson, Weiping Chu, Steffen Porwollik, et al.
Epilepsy & Behavior : E&B|October 7, 2021
Efficacy of color lenses in abolishing photosensitivity: Beyond the one-type-fits-all approach?A Checa-Ros, D Kasteleijn-Nolst Trenite, A Edson-Scott, et al.
European Journal of Immunology|September 1, 1984
Identification of a 140-kDa activation antigen as a target structure for a series of human cloned natural killer cell linesT Hercend, R Schmidt, A Brennan, et al.
The Journal of Experimental Medicine|November 1, 1983
Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector functionT Hercend, S Meuer, A Brennan, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
ACS Nano|August 22, 2018
Cancer Cell-Derived, Drug-Loaded Nanovesicles Induced by Sulfhydryl-Blocking for Effective and Safe Cancer TherapyDominique Ingato, Julius A Edson, Michael Zakharian, et al.
Biomacromolecules|March 22, 2018
Aqueous-Soluble, Acid-Transforming Chitosan for Efficient and Stimuli-Responsive Gene SilencingJulius A Edson, Dominique Ingato, Shirley Wu, et al.
Molecular & General Genetics : MGG|May 1, 1988
Early-blocked sporulation mutations alter expression of enzymes under carbon control in Bacillus subtilisS A Boylan, K T Chun, B A Edson, et al.
Cancer Research|October 15, 1990
Antitumor activity of adriamycin (hydrazone-linked) immunoconjugates compared with free adriamycin and specificity of tumor cell killingG R Braslawsky, M A Edson, W Pearce, et al.
Molecular and Cellular Biology|February 24, 2010
TEX14 interacts with CEP55 to block cell abscissionTokuko Iwamori, Naoki Iwamori, Lang Ma, et al.
Plos Genetics|October 27, 2011
Transforming growth factor β receptor type 1 is essential for female reproductive tract integrity and functionQinglei Li, Julio E Agno, Mark A Edson, et al.
Macromolecular Bioscience|April 19, 2021
Eradication of Intracellular Salmonella Typhimurium by Polyplexes of Acid-Transforming Chitosan and Fragment DNAJulius A Edson, Weiping Chu, Steffen Porwollik, et al.
Epilepsy & Behavior : E&B|October 7, 2021
Efficacy of color lenses in abolishing photosensitivity: Beyond the one-type-fits-all approach?A Checa-Ros, D Kasteleijn-Nolst Trenite, A Edson-Scott, et al.
European Journal of Immunology|September 1, 1984
Identification of a 140-kDa activation antigen as a target structure for a series of human cloned natural killer cell linesT Hercend, R Schmidt, A Brennan, et al.
The Journal of Experimental Medicine|November 1, 1983
Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector functionT Hercend, S Meuer, A Brennan, et al.
Pageof 4